Fady Malik MD PhD
Adult Congenital Heart Disease, Interventional Cardiology
Cardiology
Join to View Full Profile
280 East Grand AveSouth San Francisco, CA 94080
Phone+1 650-624-3011
Fax+1 650-624-3010
Dr. Malik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Cardiovascular Disease, 1996 - 2000- University of California (San Francisco)Residency, Internal Medicine, 1994 - 1996
- University of California San Francisco School of MedicineClass of 1994
Certifications & Licensure
CA State Medical License 1996 - 2026
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- Hospitalizations as an outcome measure in COURAGE-ALS.Stacy A Rudnicki, Ammar Al-Chalabi, Jinsy A Andrews, Adriano Chio, Philippe Corcia
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2025-06-12 - Application of the ENCALS predictive survival model in assessing the effect of the 24/44 inclusion criteria in FORTITUDE-ALS.Tyrell Simkins Lead, Jeremy M Shefner, Stuart Kupfer, Fady I Malik, Lisa Meng
Journal of Neuromuscular Diseases. 2025-05-05 - 1 citationsReldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical Trial.Jeremy M Shefner, Merit E Cudkowicz, Angela Genge, Orla Hardiman, Ammar Al-Chalabi
JAMA Neurology. 2025-05-01
Journal Articles
- Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart FailureJohn R Teerlink, David E Lanfear, Thomas M Suter, Narimon Honarpour, Siddique A Abbasi, Fady I Malik, Christopher E Kurtz, The New England Journal of Medicine
Press Mentions
Cytokinetics Presents Positive Results from Cohort 4 of REDWOOD-HCM and Long-Term Results from FOREST-HCM at the American College of Cardiology 72nd Annual Scientific SessionMarch 4th, 2023- Cytokinetics Presents New Data at the American Heart Association Scientific Sessions 2022November 7th, 2022
- Cytokinetics Presents New Data at the American Heart Association Scientific Sessions 2022November 7th, 2022
- Join now to see all
Grant Support
- Validation Of A Novel Sarcomeric High Throughput AssayNational Heart, Lung, And Blood Institute2001
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
